BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 11163098)

  • 1. Loss of tolerance to a maternal kidney transplant is selective for HLA class II: evidence from trans-vivo DTH and alloantibody analysis.
    Burlingham WJ; Jankowska-Gan E; VanBuskirk A; Orosz CG; Lee JH; Kusaka S
    Hum Immunol; 2000 Dec; 61(12):1395-402. PubMed ID: 11163098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human liver allograft acceptance and the "tolerance assay". II. Donor HLA-A, -B but not DR antigens are able to trigger regulation of DTH.
    Jankowska-Gan E; Rhein T; Haynes LD; Geissler F; Mulder A; Kalayoglu M; Sollinger H; Burlingham WJ
    Hum Immunol; 2002 Oct; 63(10):862-70. PubMed ID: 12368038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance.
    Xu Q; Lee J; Jankowska-Gan E; Schultz J; Roenneburg DA; Haynes LD; Kusaka S; Sollinger HW; Knechtle SJ; VanBuskirk AM; Torrealba JR; Burlingham WJ
    J Immunol; 2007 Mar; 178(6):3983-95. PubMed ID: 17339499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys.
    Thomas JM; Verbanac KM; Smith JP; Kasten-Jolly J; Gross U; Rebellato LM; Haisch CE; Carver FM; Thomas FT
    Transplantation; 1995 Jan; 59(2):245-55. PubMed ID: 7839448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune regulation and graft survival in kidney transplant recipients are both enhanced by human leukocyte antigen matching.
    Rodriguez DS; Jankowska-Gan E; Haynes LD; Leverson G; Munoz A; Heisey D; Sollinger HW; Burlingham WJ
    Am J Transplant; 2004 Apr; 4(4):537-43. PubMed ID: 15023145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques.
    Piazza A; Poggi E; Borrelli L; Servetti S; Monaco PI; Buonomo O; Valeri M; Torlone N; Adorno D; Casciani CU
    Transplantation; 2001 Apr; 71(8):1106-12. PubMed ID: 11374411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.
    DeVos JM; Gaber AO; Knight RJ; Land GA; Suki WN; Gaber LW; Patel SJ
    Kidney Int; 2012 Sep; 82(5):598-604. PubMed ID: 22622504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays--single-center experience.
    Mihaylova A; Baltadjieva D; Boneva P; Ivanova M; Penkova K; Marinova D; Mihailova S; Paskalev E; Simeonov P; Naumova E
    Hum Immunol; 2006 Oct; 67(10):787-94. PubMed ID: 17055355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect recognition of donor HLA-DR peptides in organ allograft rejection.
    Liu Z; Colovai AI; Tugulea S; Reed EF; Fisher PE; Mancini D; Rose EA; Cortesini R; Michler RE; Suciu-Foca N
    J Clin Invest; 1996 Sep; 98(5):1150-7. PubMed ID: 8787678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR matching and anti-donor-specific antibodies in kidney transplant recipients.
    Valeri M; Piazza A; Torlone N; Poggi E; Monaco PI; Provenzani L; Adorno D; Casciani CU
    Transplant Proc; 1992 Dec; 24(6):2514-6. PubMed ID: 1465850
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of indirect allorecognition in experimental late acute rejection.
    Vella JP; Vos L; Carpenter CB; Sayegh MH
    Transplantation; 1997 Dec; 64(12):1823-8. PubMed ID: 9422426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HLA-DR phenotype of the responder is predictive of humoral response against HLA class I antigens.
    Dankers MK; Roelen DL; Nagelkerke NJ; de Lange P; Persijn GG; Doxiadis II; Claas FH
    Hum Immunol; 2004 Jan; 65(1):13-9. PubMed ID: 14700591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
    Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
    Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrogation of antibody-mediated allograft rejection by regulatory CD4 T cells with indirect allospecificity.
    Callaghan CJ; Rouhani FJ; Negus MC; Curry AJ; Bolton EM; Bradley JA; Pettigrew GJ
    J Immunol; 2007 Feb; 178(4):2221-8. PubMed ID: 17277127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity.
    Reinsmoen NL; Matas AJ
    Transplantation; 1993 May; 55(5):1017-23. PubMed ID: 7684534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity.
    VanBuskirk AM; Wakely ME; Sirak JH; Orosz CG
    Transplantation; 1998 Apr; 65(8):1115-23. PubMed ID: 9583874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
    Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
    Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-vivo delayed type hypersensitivity assay for antigen specific regulation.
    Jankowska-Gan E; Hegde S; Burlingham WJ
    J Vis Exp; 2013 May; (75):e4454. PubMed ID: 23665523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific antibodies present at the time of kidney transplantation in immunologically unmodified patients increase the risk of acute rejection.
    Gupta A; Murillo D; Yarlagadda SG; Wang CJ; Nawabi A; Schmitt T; Brimacombe M; Bryan CF
    Transpl Immunol; 2016 Jul; 37():18-22. PubMed ID: 27137749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.